Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P‐glycoprotein and enhancing apoptosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|137|8|2029-2039

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.8, 2015-10, pp. : 2029-2039

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predicting Chemotherapy Response to Paclitaxel-Based Therapy in Advanced Non-Small-Cell Lung Cancer with P-Glycoprotein Expression

By  

Respiration, Vol. 70, Iss. 1, 2003-02 ,pp. : 32-35

Karger

Access to resources Recommend Favorite

P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells

By Navarro Gemma   Sawant Rupa R   Biswas Swati   Essex Sean   Tros de Ilarduya Conchita   Torchilin Vladimir P  

Nanomedicine, Vol. 7, Iss. 1, 2012-01 ,pp. : 65-78

Future Medicine

Access to resources Recommend Favorite

P-Glycoprotein Turned Twenty: Are We Any Closer to Fight Drug Resistance in Cancer?

By  

Oncology Research and Treatment, Vol. 23, Iss. 4, 2000-09 ,pp. : 316-317

Karger

Access to resources Recommend Favorite

Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P‐glycoprotein

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 1010-1023

John Wiley & Sons Inc

Access to resources Recommend Favorite

An exercise regimen prevents development paclitaxel induced peripheral neuropathy in a mouse model

By  

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, Vol. 20, Iss. 1, 2015-03 ,pp. : 7-14

John Wiley & Sons Inc

Access to resources Recommend Favorite